Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (331-340 of 390) with videos related to

Pageof 39
Sort By:
British Journal of Haematology|July 7, 2024
Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamideKentaro Ido, Hirohisa Nakamae, Norimichi Hattori, et al.
Bone Marrow Transplantation|September 25, 2024
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphomaMasashi Nishikubo, Yoshimitsu Shimomura, Yosuke Nakaya, et al.
Leukemia|November 24, 2021
Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemiaYoshimitsu Shimomura, Tomotaka Sobue, Shigeki Hirabayashi, et al.
Annals of Hematology|February 8, 2025
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 studySatoshi Iyama, SungGi Chi, Masashi Idogawa, et al.
Annals of Hematology|April 13, 2023
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfanTomoki Iemura, Tadakazu Kondo, Atsushi Ueda, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide RegistrySumiko Kobayashi, Hidehiro Itonaga, Shuhei Kurosawa, et al.
British Journal of Haematology|July 17, 2025
A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donorsYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
Blood|May 19, 2010
Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective studyMasakatsu Hishizawa, Junya Kanda, Atae Utsunomiya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
American Journal of Hematology|May 1, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of RuxolitinibKazuki Sakatoku, Hirohisa Nakamae, Makoto Murata, et al.
Pageof 39

Showing results (331-340 of 390) with videos related to

Sort By:
Pageof 39
British Journal of Haematology|July 7, 2024
Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamideKentaro Ido, Hirohisa Nakamae, Norimichi Hattori, et al.
Bone Marrow Transplantation|September 25, 2024
Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation in adults with relapsed/refractory non-Hodgkin lymphomaMasashi Nishikubo, Yoshimitsu Shimomura, Yosuke Nakaya, et al.
Leukemia|November 24, 2021
Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemiaYoshimitsu Shimomura, Tomotaka Sobue, Shigeki Hirabayashi, et al.
Annals of Hematology|February 8, 2025
Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 studySatoshi Iyama, SungGi Chi, Masashi Idogawa, et al.
Annals of Hematology|April 13, 2023
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfanTomoki Iemura, Tadakazu Kondo, Atsushi Ueda, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide RegistrySumiko Kobayashi, Hidehiro Itonaga, Shuhei Kurosawa, et al.
British Journal of Haematology|July 17, 2025
A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donorsYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
Blood|May 19, 2010
Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective studyMasakatsu Hishizawa, Junya Kanda, Atae Utsunomiya, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2020
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter AnalysisTakayoshi Tachibana, Junya Kanda, Takuma Ishizaki, et al.
American Journal of Hematology|May 1, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of RuxolitinibKazuki Sakatoku, Hirohisa Nakamae, Makoto Murata, et al.
Pageof 39